BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aloysius H, Hu L. Synthesis and evaluation of new peptide-linked doxorubicin conjugates as prodrugs activated by prostate-specific antigen. Med Chem Res 2020;29:1280-99. [DOI: 10.1007/s00044-020-02573-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Xue Y, Bai H, Peng B, Fang B, Baell J, Li L, Huang W, Voelcker NH. Stimulus-cleavable chemistry in the field of controlled drug delivery. Chem Soc Rev 2021;50:4872-931. [DOI: 10.1039/d0cs01061h] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Bhilare NV, Marulkar VS, Kumar D, Chatap VK, Patil KS, Shirote PJ. An insight into prodrug strategy for the treatment of Alzheimer’s disease. Med Chem Res. [DOI: 10.1007/s00044-022-02859-1] [Reference Citation Analysis]
3 Aloysius H, Hu L. Synthesis and evaluation of new 4-peptidamido-2-fluorobenzyl phosphoramide mustard conjugates as prodrugs activated by prostate-specific antigen. Med Chem Res 2020;29:1264-79. [DOI: 10.1007/s00044-020-02572-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pereira S, Ma G, Na L, Hudoklin S, Kreft ME, Kostevsek N, Al-Jamal WT. Encapsulation of doxorubicin prodrug in heat-triggered liposomes overcomes off-target activation for advanced prostate cancer therapy. Acta Biomater 2021:S1742-7061(21)00826-6. [PMID: 34954416 DOI: 10.1016/j.actbio.2021.12.019] [Reference Citation Analysis]